drugset / Trial / NCT01349777

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

NCT01349777 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

This study is an open label, multi-center, randomized trial, which is designed to evaluate the efficacy and safety of clopidogrel derivative (Pregrel®) therapy for 12 months in patients undergoing PCI compared to conventional clopidogrel (Plavix®).

Timeline

Start
2010-03-15
Primary completion
2017-03-14
Completion
2017-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg —